FI77877C
(fi)
*
|
1979-04-20 |
1989-05-10 |
Technobiotic Ltd |
Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
|
US4460685A
(en)
*
|
1980-05-29 |
1984-07-17 |
New York University |
Method of enhancing the production of human γ Interferon
|
DE3280127D1
(de)
*
|
1981-03-27 |
1990-04-12 |
Ici Plc |
Genetisch modifizierte mikroorganismen.
|
JPS58146281A
(ja)
*
|
1981-10-19 |
1983-08-31 |
Suntory Ltd |
酵母細胞の形質転換法
|
US4775622A
(en)
*
|
1982-03-08 |
1988-10-04 |
Genentech, Inc. |
Expression, processing and secretion of heterologous protein by yeast
|
HU204097B
(en)
*
|
1982-05-19 |
1991-11-28 |
Gist Brocades Nv |
Process for producing cloning system relating to kluyveromyces species
|
GB2125047B
(en)
*
|
1982-08-09 |
1986-02-19 |
Ciba Geigy Ag |
Yeast hybrid vectors and their use for the production of polypeptides
|
IL69202A
(en)
*
|
1982-09-08 |
1991-08-16 |
Smith Kline Rit |
Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof
|
JPH0716432B2
(ja)
*
|
1982-10-20 |
1995-03-01 |
サントリー株式会社 |
酵母の高発現ベクタープラスミドを用いたペプチドの生産方法
|
EP0116201B1
(de)
*
|
1983-01-12 |
1992-04-22 |
Chiron Corporation |
Sekretorische Expression in Eukaryoten
|
NO172595C
(no)
*
|
1983-02-07 |
1993-08-11 |
Battelle Memorial Institute |
Fremgangsmaate og ekspresjonsplasmid for fremstilling av hemagglutinin under kontroll av drosophila hsp-promoter
|
CA1341116C
(en)
*
|
1983-02-22 |
2000-10-17 |
Rae Lyn Burke |
Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
|
US4876197A
(en)
*
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
US4661454A
(en)
*
|
1983-02-28 |
1987-04-28 |
Collaborative Research, Inc. |
GAL1 yeast promoter linked to non galactokinase gene
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
JPS60501140A
(ja)
*
|
1983-04-22 |
1985-07-25 |
アムジエン |
酵母による外因性ポリペプチドの分泌
|
US7198919B1
(en)
|
1983-04-25 |
2007-04-03 |
Genentech, Inc. |
Use of alpha factor sequences in yeast expression systems
|
ZA843275B
(en)
*
|
1983-05-05 |
1984-12-24 |
Hoffmann La Roche |
Novel vectors for interferon expression
|
WO1984004539A1
(fr)
*
|
1983-05-19 |
1984-11-22 |
Transgene Sa |
Production de la catechol 2,3-oxygenase par des levures, plasmide pour sa mise en oeuvre et application
|
EP0129268B1
(de)
*
|
1983-05-19 |
1989-10-04 |
Unilever N.V. |
Verbesserungen in der Expression von neu eingeführten Genen in Hefezellen
|
US4870008A
(en)
*
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
WO1985001516A1
(fr)
*
|
1983-10-03 |
1985-04-11 |
Transgene S.A. |
Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
|
FR2552776B1
(fr)
*
|
1983-10-03 |
1986-05-09 |
Transgene Sa |
Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
|
FR2562090B2
(fr)
*
|
1984-03-27 |
1988-04-08 |
Transgene Sa |
Proteine antigenique de la rage glycosylee
|
US5639639A
(en)
*
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
PH23920A
(en)
*
|
1983-12-20 |
1990-01-23 |
Cetus Corp |
Glucoamylase cdna
|
GB8334261D0
(en)
*
|
1983-12-22 |
1984-02-01 |
Bass Plc |
Fermentation processes
|
EP0154576A1
(de)
*
|
1984-02-06 |
1985-09-11 |
INTERFERON SCIENCES, INC a Delaware Corporation |
Hybrid-Nucleinsäuresequenzen mit tandemartig angeordneten Genen
|
US4626505A
(en)
*
|
1984-02-24 |
1986-12-02 |
E. I. Du Pont De Nemours And Company |
Selectable markers for yeast transformation
|
US4745057A
(en)
*
|
1984-05-18 |
1988-05-17 |
Eli Lilly And Company |
Method, vectors and transformants for high expression of heterologous polypeptides in yeast
|
DK58285D0
(da)
*
|
1984-05-30 |
1985-02-08 |
Novo Industri As |
Peptider samt fremstilling og anvendelse deraf
|
US5683688A
(en)
*
|
1984-05-31 |
1997-11-04 |
Genentech, Inc. |
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
|
SE8403929L
(sv)
*
|
1984-07-31 |
1986-02-21 |
Sten Gatenbeck |
Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
|
US4752473A
(en)
*
|
1984-10-12 |
1988-06-21 |
The Regents Of The University Of California |
Expression of glycosylated human influenza hemagglutinin proteins
|
CA1341423C
(en)
|
1984-10-31 |
2003-03-04 |
Paul A. Luciw |
Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
|
US7393949B1
(en)
|
1987-12-24 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Human immunodeficiency virus (HIV) nucleotide sequences
|
US7285271B1
(en)
|
1984-10-31 |
2007-10-23 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenic composition comprising an HIV gag or env polypeptide
|
US7273695B1
(en)
*
|
1984-10-31 |
2007-09-25 |
Novartis Vaccines And Diagnostics, Inc. |
HIV immunoassays using synthetic envelope polypeptides
|
US4812405A
(en)
*
|
1986-02-18 |
1989-03-14 |
Phillips Petroleum Company |
Double auxotrophic mutants of Pichia pastoris and methods for preparation
|
JPS6447380A
(en)
*
|
1987-08-19 |
1989-02-21 |
Agency Ind Science Techn |
Steroid-oxidizing yeast strain
|
US5580734A
(en)
*
|
1990-07-13 |
1996-12-03 |
Transkaryotic Therapies, Inc. |
Method of producing a physical map contigous DNA sequences
|
ATE158816T1
(de)
|
1990-11-26 |
1997-10-15 |
Genetics Inst |
Expression von pace in wirtszellen und verfahren zu dessen verwendung
|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
DE69505076T2
(de)
*
|
1994-07-29 |
1999-02-25 |
Teijin Ltd., Osaka |
Trypsintyp-Enzyme, dafür kodierende Nukleinsäuresequenz und Verfahren zur Herstellung des Enzymes
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
WO1998013473A1
(en)
|
1996-09-25 |
1998-04-02 |
Vanderbilt University |
Genetically engineered yeast with modified signal peptidase complex
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
EP2278011A3
(de)
|
1998-01-14 |
2012-03-07 |
Novartis Vaccines and Diagnostics S.r.l. |
Antigene aus neisseria meningitidis
|
ATE393912T1
(de)
|
1998-02-04 |
2008-05-15 |
Invitrogen Corp |
Microarrays und ihre verwendungen
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
AU761780B2
(en)
|
1998-05-01 |
2003-06-12 |
Glaxosmithkline Biologicals Sa |
Neisseria meningitidis antigens and compositions
|
US7081360B2
(en)
*
|
1998-07-28 |
2006-07-25 |
Cadus Technologies, Inc. |
Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties
|
GB9902000D0
(en)
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
EP1228217B1
(de)
|
1999-04-30 |
2012-11-21 |
Novartis Vaccines and Diagnostics S.r.l. |
Konservierte antigene aus neisseria
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
AU784203B2
(en)
|
1999-10-29 |
2006-02-23 |
Glaxosmithkline Biologicals S.A. |
Neisserial antigenic peptides
|
US6232074B1
(en)
*
|
1999-12-10 |
2001-05-15 |
Complegen, Inc. |
Functional gene array in yeast
|
EP2275129A3
(de)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Ergänzter Außenmembranvesikel-Impfstoff gegen Meningokokken
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
US7780967B2
(en)
*
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
US8632785B2
(en)
*
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
PT1398038E
(pt)
*
|
2000-02-08 |
2007-02-28 |
Allergan Inc |
Composições farmacêuticas de toxina botulínica
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
EP1276756A4
(de)
|
2000-04-12 |
2004-06-09 |
Human Genome Sciences Inc |
Albumin fusionsproteine
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
JP2004511753A
(ja)
|
2000-05-04 |
2004-04-15 |
イエール ユニバーシティー |
タンパク質活性のスクリーニング用タンパク質チップ
|
EP2322644A1
(de)
*
|
2000-06-28 |
2011-05-18 |
GlycoFi, Inc. |
Verfahren für die Herstellung modifizierter Glykoproteine
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US6737262B1
(en)
*
|
2000-07-11 |
2004-05-18 |
Robert I. Bolla |
Animal feed containing polypeptides
|
JP2002057727A
(ja)
*
|
2000-08-10 |
2002-02-22 |
Hitachi Ltd |
半導体集積回路および光通信モジュール
|
MX357775B
(es)
|
2000-10-27 |
2018-07-20 |
J Craig Venter Inst Inc |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
US7083787B2
(en)
*
|
2000-11-15 |
2006-08-01 |
Globeimmune, Inc. |
Yeast-dendritic cell vaccines and uses thereof
|
US6861237B2
(en)
|
2000-11-30 |
2005-03-01 |
Novo Nordisk A/S |
Production of heterologous polypeptides in yeast
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
US20050054051A1
(en)
*
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7507413B2
(en)
*
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
DE10123980B4
(de)
*
|
2001-05-17 |
2008-01-10 |
Tesa Ag |
Abschlussbandage
|
ATE406912T1
(de)
|
2001-12-12 |
2008-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia tracheomatis
|
WO2003059934A2
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
ES2545090T3
(es)
*
|
2001-12-21 |
2015-09-08 |
Human Genome Sciences, Inc. |
Proteínas de fusión de albúmina y GCSF
|
WO2003099854A2
(en)
|
2002-05-24 |
2003-12-04 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
US20040018581A1
(en)
*
|
2002-07-24 |
2004-01-29 |
Pharmacia And Upjohn Company |
Method for discovering substances for inhibiting enzymes
|
AU2003288660A1
(en)
|
2002-11-15 |
2004-06-15 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
US8343502B2
(en)
*
|
2002-12-16 |
2013-01-01 |
Globeimmune, Inc. |
Yeast-based vaccines as immunotherapy
|
ES2676503T3
(es)
*
|
2002-12-16 |
2018-07-20 |
Globeimmune, Inc. |
Vacunas basadas en levadura como inmunoterapia
|
US7439042B2
(en)
*
|
2002-12-16 |
2008-10-21 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis C infection
|
EP1433842B1
(de)
|
2002-12-18 |
2011-01-05 |
Roche Diagnostics GmbH |
Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
|
ATE494367T1
(de)
*
|
2002-12-18 |
2011-01-15 |
Hoffmann La Roche |
Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität
|
DE60319333D1
(de)
*
|
2002-12-20 |
2008-04-10 |
Roche Diagnostics Gmbh |
Hitzelabile Desoxyribonuklease I-Varianten
|
EP1594530A4
(de)
|
2003-01-22 |
2006-10-11 |
Human Genome Sciences Inc |
Albuminfusionsproteine
|
US7332299B2
(en)
*
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
EP1460425A1
(de)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Entglykosilierte Enzymen für Konjugaten
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US20040248323A1
(en)
|
2003-06-09 |
2004-12-09 |
Protometrix, Inc. |
Methods for conducting assays for enzyme activity on protein microarrays
|
AU2004203649B2
(en)
|
2003-08-12 |
2006-01-12 |
F. Hoffmann-La Roche Ag |
Thermostable Taq polymerase fragment
|
ME01366B
(me)
|
2003-11-21 |
2013-12-20 |
Nps Allelix Corp |
POSTUPAK ZA PROIZVODNJU PEPTIDA 2 NALIK NA GLUKAGON l NJIHOVIH ANALOGA
|
JP4411192B2
(ja)
*
|
2003-12-05 |
2010-02-10 |
エフ.ホフマン−ラ ロシュ アーゲー |
組換えで発現されるカルボキシペプチダーゼbおよびその精製
|
GB0329722D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Modified plasmid and use thereof
|
GB0329681D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Gene expression technique
|
EP2460533A3
(de)
|
2004-10-18 |
2014-01-08 |
Globeimmune, Inc. |
Therapeutikum auf Hefebasis gegen chronische Hepatitis-C-Infection
|
EP1831375B1
(de)
|
2004-12-23 |
2014-07-16 |
Novozymes Biopharma DK A/S |
Genexpressionsmethode
|
JP4690787B2
(ja)
*
|
2005-06-14 |
2011-06-01 |
株式会社日立製作所 |
微生物検知チップ及び微生物検知システム並びに微生物検知方法
|
CN101300346B
(zh)
|
2005-06-24 |
2013-04-24 |
帝人制药株式会社 |
新型生理物质nesfatin及其相关物质、以及它们的用途
|
US20100034840A1
(en)
*
|
2005-07-11 |
2010-02-11 |
David Apelian |
Compositions and methods for eliciting an immune response to escape mutants of targeted therapies
|
PL1926749T3
(pl)
*
|
2005-09-14 |
2011-12-30 |
Sanofi Aventis Deutschland |
Cięcie prekursorów insuliny przez wariant trypsyny
|
JP2009509970A
(ja)
*
|
2005-09-22 |
2009-03-12 |
プロサイ インコーポレイテッド |
酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法
|
US20070172503A1
(en)
|
2005-12-13 |
2007-07-26 |
Mycologics,Inc. |
Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines
|
US7745128B2
(en)
*
|
2006-03-27 |
2010-06-29 |
Globeimmune, Inc. |
Ras mutation and compositions and methods related thereto
|
DK2054431T3
(da)
|
2006-06-09 |
2012-01-02 |
Novartis Ag |
Konformere af bakterielle adhæsiner
|
ES2527756T3
(es)
*
|
2007-02-02 |
2015-01-29 |
Globeimmune, Inc. |
Procedimientos mejorados de producción de vacunas con base de levadura
|
EP2068914A4
(de)
*
|
2007-02-09 |
2011-07-20 |
Medimmune Llc |
Antikörperbibliothekdisplay durch hefezellplasmamembrane
|
MX2009010066A
(es)
*
|
2007-03-19 |
2009-10-12 |
Globeimmune Inc |
Composiciones y metodos para la ablacion especifica de la evasion mutacional de terapias especificas para cancer.
|
CN101835801B
(zh)
|
2007-08-08 |
2014-09-10 |
诺维信生物制药丹麦公司 |
转铁蛋白变体和偶联物
|
JP2012503011A
(ja)
|
2008-09-19 |
2012-02-02 |
グローブイミューン,インコーポレイテッド |
慢性c型肝炎ウイルス感染の免疫療法
|
JP2012516878A
(ja)
|
2009-02-06 |
2012-07-26 |
ノボザイムス バイオファーマ デーコー アクティーゼルスカブ |
精製プロセス
|
JP5936112B2
(ja)
|
2009-02-11 |
2016-06-15 |
アルブミディクス アクティーゼルスカブ |
アルブミン変異体及び複合体
|
US10383924B2
(en)
|
2009-04-17 |
2019-08-20 |
Globeimmune, Inc. |
Combination immunotherapy compositions against cancer and methods
|
EP2477647B1
(de)
|
2009-09-14 |
2016-01-13 |
The Regents of the University of Colorado |
Modulation von immuntherapeutischen produkten auf hefebasis und reaktionen
|
BR112012022939A2
(pt)
|
2010-03-11 |
2016-08-02 |
Immune Design Corp |
composição farmacêutica para uso em um método de imunização de um indivíduo em necessidade do mesmo contra um vírus influenza
|
EP2380905A1
(de)
|
2010-04-19 |
2011-10-26 |
Thrombotargets Europe, S.L. |
Phospholipidangereicherte Vesikel mit Gewebefaktor mit blutstillenden Aktivitäten sowie Verwendungen davon
|
EP2651439B1
(de)
|
2010-12-17 |
2018-09-19 |
Globeimmune, Inc. |
Zusammensetzungen und verfahren zur behandlung oder vorbeugung von menschlicher adenovirus-36-infektion
|
US8877205B2
(en)
|
2011-02-12 |
2014-11-04 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis B infection
|
AU2012228937B2
(en)
|
2011-03-17 |
2016-11-03 |
Globeimmune, Inc. |
Yeast-Brachyury immunotherapeutic compositions
|
ES2671381T3
(es)
|
2011-06-14 |
2018-06-06 |
Globeimmune, Inc. |
Composiciones inmunoterapéuticas para el tratamiento o prevención de infección por virus de hepatitis delta
|
RU2642300C2
(ru)
|
2011-08-17 |
2018-01-24 |
Глоубиммьюн, Инк. |
Иммунотерапевтические композиции на основе дрожжей-muc1 и способы их применения
|
CN104685360B
(zh)
|
2012-06-26 |
2018-02-13 |
比奥德希克斯股份有限公司 |
用于选择和去选择用产生免疫应答的疗法治疗的癌症患者的质谱方法
|
MX2015013380A
(es)
|
2013-03-19 |
2016-01-08 |
Globeimmune Inc |
Inmunoterapia para cordoma a base de levadura.
|
TWI626948B
(zh)
|
2013-03-26 |
2018-06-21 |
環球免疫公司 |
治療或預防人類免疫缺乏病毒感染之組合物及方法
|
TWI654200B
(zh)
|
2013-08-30 |
2019-03-21 |
環球免疫公司 |
治療或預防結核病的組合物及方法
|
WO2015157639A1
(en)
|
2014-04-11 |
2015-10-15 |
Globeimmune, Inc. |
Yeast-based immunotherapy and type i interferon sensitivity
|
PL3628680T3
(pl)
|
2014-06-12 |
2022-01-10 |
Ra Pharmaceuticals, Inc. |
Modulowanie aktywności dopełniacza
|
HRP20211824T1
(hr)
|
2015-01-28 |
2022-03-04 |
Ra Pharmaceuticals, Inc. |
Modulatori aktivnosti komplementa
|
TWI748957B
(zh)
|
2015-08-03 |
2021-12-11 |
美商環球免疫公司 |
經修飾之酵母-短尾畸型(Brachyury)免疫治療組合物
|
HRP20230182T1
(hr)
|
2015-12-16 |
2023-04-14 |
Ra Pharmaceuticals, Inc. |
Modulatori aktivnosti komplementa
|
CA3045114A1
(en)
|
2016-12-07 |
2018-06-14 |
Ra Pharmaceuticals, Inc. |
Modulators of complement activity
|
MX2019013331A
(es)
|
2017-05-10 |
2020-07-27 |
Baymedica Inc |
Sistemas de produccion recombinante para policetidos prenilados de la familia de los cannabinoides.
|
TW202041245A
(zh)
|
2019-03-08 |
2020-11-16 |
美商美威高能離子醫療系統公司 |
用於粒子治療系統之準直儀及降能器
|